- €84.36m
- €100.47m
- €60.66m
- 56
- 55
- 66
- 63
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.2 | 18 | 18.3 | 27.9 | 60.7 |
Cost of Revenue | |||||
Gross Profit | 8.68 | 15.7 | 15.4 | 21.6 | 36.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.8 | 14.1 | 14.8 | 25.7 | 54.9 |
Operating Profit | 2.38 | 3.83 | 3.44 | 2.28 | 5.78 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.36 | 3.75 | 3.36 | 3.2 | 4.55 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.62 | 2.58 | 2.72 | 3.85 | 1.69 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.56 | 2.53 | 2.55 | 3.65 | 1.66 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.56 | 2.53 | 2.55 | 3.65 | 1.66 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.074 | 0.101 | 0.1 | 0.117 | 0.086 |
Dividends per Share |